AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MY FOODIE BOX LTD

0.004

0.000

Volume:- -

Turnover:- -

Market Cap:111.33K

PE:-0.46

High:0.004

Open:0.004

Low:0.004

Close:0.004

52wk High:0.020

52wk Low:0.004

Shares:27.83M

Float Shares:9.05M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.009

EPS(LYR):-0.009

ROE:-2349.63%

ROA:-609.17%

PB:-0.11

PE(LYR):-0.46

Loading ...

Overview Company News Filings

Completion of Consolidation of Capital-MBX

MBX Biosciences Prices Upsized $200 Million Common Stock Offering

MT Newswires Live

MBX Biosciences Files for Public Offering of 10 Million Shares

MT Newswires Live

MBX Biosciences Says Mid-Stage Study of Canvuparatide Meets Primary Endpoint in Hypoparathyroidism

MT Newswires Live

My Foodie Box Ltd - to Acquire Australian Gold, Copper and Rare Earths Projects and Relist on ASX

THOMSON REUTERS

My Foodie Box Ltd - to Raise a$5 Mln at a$0.02 per Share

THOMSON REUTERS

My Foodie Box Ltd - Gregor Partington to Be Appointed as CEO

THOMSON REUTERS

MBX Biosciences' Hypoparathyroidism Treatment a 'Key Catalyst,' Oppenheimer Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MBX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MBX.AU\",,,,,undefined,":{"symbol":"MBX.AU","market":"AU","secType":"STK","nameCN":"MY FOODIE BOX LTD","latestPrice":0.004,"timestamp":1771909200000,"preClose":0.004,"halted":8,"volume":0,"delay":0,"changeRate":0,"nameEN":"MY FOODIE BOX LTD","floatShares":9052271,"shares":27832708,"eps":-0.008656,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-24 16:00:00 AEDT","open":0.004,"high":0.004,"low":0.004,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.008656,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771974000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.004,"openAndCloseTimeList":[[1771887600000,1771909200000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MBX.AU\",,,,,undefined,":{"symbol":"MBX.AU","floatShares":9052271,"roa":"-609.17%","roe":"-2349.63%","lyrEps":-0.008656,"shares":27832708,"dividePrice":0,"high":0.004,"amplitude":0,"preClose":0.004,"low":0.004,"week52Low":0.004,"pbRate":"-0.11","psRate":"5.00","week52High":0.02,"institutionHeld":0,"latestPrice":0.004,"eps":-0.008656,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.008656,"open":0.004},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-10-20","symbol":"MBX.AU","oldSymbol":"MBX","defaultRemindTime":1760914800000,"newSymbol":"TR8.AU","exchange":"ASX","type":"symbolChange","dateTimestamp":1760878800000},{"market":"AU","date":"2025-10-06","symbol":"MBX.AU","defaultRemindTime":1759705200000,"type":"split","dateTimestamp":1759669200000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575236628","title":"Completion of  Consolidation of Capital-MBX","url":"https://stock-news.laohu8.com/highlight/detail?id=2575236628","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575236628?lang=en_us&edition=fundamental","pubTime":"2025-10-14 06:11","pubTimestamp":1760393501,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251013:nASXZps16","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nASX4mvDY4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX.AU","BK7040"],"gpt_icon":0},{"id":"2570423061","title":"MBX Biosciences Prices Upsized $200 Million Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2570423061","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570423061?lang=en_us&edition=fundamental","pubTime":"2025-09-25 16:09","pubTimestamp":1758787794,"startTime":"0","endTime":"0","summary":"MBX Biosciences (MBX) said late Wednesday it priced its upsized public offering of 11.1 million common shares at $18 each, for about $199.9 million in expected gross proceeds.Underwriters have a 30-da","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7040","MBX.AU","MBX","BK4007"],"gpt_icon":0},{"id":"2569673076","title":"MBX Biosciences Files for Public Offering of 10 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2569673076","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569673076?lang=en_us&edition=fundamental","pubTime":"2025-09-23 04:37","pubTimestamp":1758573463,"startTime":"0","endTime":"0","summary":"MBX Biosciences  said late Monday it filed a registration statement for a public offering of 10 million common shares.The company will grant underwriters a 30-day overallotment option to buy up to an additional 1.5 million common shares, according to a statement.Shares fell 4.5% during after-hours trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MBX","MBX.AU","BK4007","BK7040"],"gpt_icon":0},{"id":"2569841117","title":"MBX Biosciences Says Mid-Stage Study of Canvuparatide Meets Primary Endpoint in Hypoparathyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2569841117","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569841117?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:16","pubTimestamp":1758543401,"startTime":"0","endTime":"0","summary":"MBX Biosciences  said Monday that a mid-stage study of canvuparatide has met its primary endpoint in adult patients with chronic hypoparathyroidism, with 63% of treated patients reaching responder status at 12 weeks.Data from the study's open-label extension showed that 79% of patients achieved responder status at six months, the company said.Responders were defined as patients who maintained serum calcium levels within the normal range while remaining independence from conventional therapy, MBX said.The company said the therapy was well tolerated, with no treatment-related serious adverse events, and preparations are underway for a late-stage trial next year.Shares of MBX Biosciences were up 90% in recent Monday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"158b79a33791d00a070a127d7a344b1f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MBX.AU","BK4007","SSI","BK7040","MBX"],"gpt_icon":0},{"id":"2564989376","title":"My Foodie Box Ltd - to Acquire Australian Gold, Copper and Rare Earths Projects and Relist on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2564989376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564989376?lang=en_us&edition=fundamental","pubTime":"2025-09-01 13:20","pubTimestamp":1756704009,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UN03D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7040","MBX.AU"],"gpt_icon":0},{"id":"2564893768","title":"My Foodie Box Ltd - to Raise a$5 Mln at a$0.02 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2564893768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564893768?lang=en_us&edition=fundamental","pubTime":"2025-09-01 13:20","pubTimestamp":1756704009,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UN03D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7040","MBX.AU"],"gpt_icon":0},{"id":"2564766893","title":"My Foodie Box Ltd - Gregor Partington to Be Appointed as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2564766893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564766893?lang=en_us&edition=fundamental","pubTime":"2025-09-01 13:20","pubTimestamp":1756704009,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UN03D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBX.AU","BK7040"],"gpt_icon":0},{"id":"2551129520","title":"MBX Biosciences' Hypoparathyroidism Treatment a 'Key Catalyst,' Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2551129520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551129520?lang=en_us&edition=fundamental","pubTime":"2025-07-16 22:43","pubTimestamp":1752677015,"startTime":"0","endTime":"0","summary":"MBX Biosciences'  hypoparathyroidism drug, canvuparatide, is a \"key catalyst\" for the company as its potentially favorable efficacy to current treatments could be a $2 billion global peak sales opportunity, said Oppenheimer said in a Wednesday note.Oppenheimer said its enthusiasm for MBX Biosciences stems from the company's precision endocrine peptide platform and its potential to \"redefine standards\" in endocrine and metabolic disease treatment.The firm initiated coverage on MBX Biosciences with an outperform rating and a $38 price target.Price: 12.40, Change: -1.00, Percent Change: -7.46","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4127","MBX","MBX.AU","BK7040","OPY"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}